Cargando…

Post COVID-19 vaccine deaths - Singapore’s early experience

Singapore has been using mRNA vaccines developed by Pfizer-BioNTech and Moderna as part of the nation’s COVID vaccination program since 30 December 2020. From 1 February 2021–30 June 2021, a total of 34 deaths that occurred within 72 h of the deceased receiving their COVID-19 vaccination were referr...

Descripción completa

Detalles Bibliográficos
Autores principales: YEO, Audrey, KUEK, Benjamin, LAU, Mandy, TAN, Shi Rui, CHAN, Shijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767909/
https://www.ncbi.nlm.nih.gov/pubmed/35078041
http://dx.doi.org/10.1016/j.forsciint.2022.111199
_version_ 1784634813315022848
author YEO, Audrey
KUEK, Benjamin
LAU, Mandy
TAN, Shi Rui
CHAN, Shijia
author_facet YEO, Audrey
KUEK, Benjamin
LAU, Mandy
TAN, Shi Rui
CHAN, Shijia
author_sort YEO, Audrey
collection PubMed
description Singapore has been using mRNA vaccines developed by Pfizer-BioNTech and Moderna as part of the nation’s COVID vaccination program since 30 December 2020. From 1 February 2021–30 June 2021, a total of 34 deaths that occurred within 72 h of the deceased receiving their COVID-19 vaccination were referred to the Forensic Medicine Division of the Health Sciences Authority of Singapore. Autopsies, histological sampling and ancillary investigations consisting of total tryptase level, Immunoglobulin E (IgE), and C-reactive Protein (CRP), were performed on 29 of these cases. Our study has shown no definite causative relationship between the mRNA vaccination and deaths of individuals who died within 72 h after receiving the vaccination, in particular with regards to anaphylactic reactions, myocarditis and pericarditis, and thrombotic complications. Further studies may consider increasing the incident time frame from 72 h to seven days post-vaccination or longer to include any potential delayed presentation of adverse effects.
format Online
Article
Text
id pubmed-8767909
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-87679092022-01-19 Post COVID-19 vaccine deaths - Singapore’s early experience YEO, Audrey KUEK, Benjamin LAU, Mandy TAN, Shi Rui CHAN, Shijia Forensic Sci Int Article Singapore has been using mRNA vaccines developed by Pfizer-BioNTech and Moderna as part of the nation’s COVID vaccination program since 30 December 2020. From 1 February 2021–30 June 2021, a total of 34 deaths that occurred within 72 h of the deceased receiving their COVID-19 vaccination were referred to the Forensic Medicine Division of the Health Sciences Authority of Singapore. Autopsies, histological sampling and ancillary investigations consisting of total tryptase level, Immunoglobulin E (IgE), and C-reactive Protein (CRP), were performed on 29 of these cases. Our study has shown no definite causative relationship between the mRNA vaccination and deaths of individuals who died within 72 h after receiving the vaccination, in particular with regards to anaphylactic reactions, myocarditis and pericarditis, and thrombotic complications. Further studies may consider increasing the incident time frame from 72 h to seven days post-vaccination or longer to include any potential delayed presentation of adverse effects. Elsevier B.V. 2022-03 2022-01-19 /pmc/articles/PMC8767909/ /pubmed/35078041 http://dx.doi.org/10.1016/j.forsciint.2022.111199 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
YEO, Audrey
KUEK, Benjamin
LAU, Mandy
TAN, Shi Rui
CHAN, Shijia
Post COVID-19 vaccine deaths - Singapore’s early experience
title Post COVID-19 vaccine deaths - Singapore’s early experience
title_full Post COVID-19 vaccine deaths - Singapore’s early experience
title_fullStr Post COVID-19 vaccine deaths - Singapore’s early experience
title_full_unstemmed Post COVID-19 vaccine deaths - Singapore’s early experience
title_short Post COVID-19 vaccine deaths - Singapore’s early experience
title_sort post covid-19 vaccine deaths - singapore’s early experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767909/
https://www.ncbi.nlm.nih.gov/pubmed/35078041
http://dx.doi.org/10.1016/j.forsciint.2022.111199
work_keys_str_mv AT yeoaudrey postcovid19vaccinedeathssingaporesearlyexperience
AT kuekbenjamin postcovid19vaccinedeathssingaporesearlyexperience
AT laumandy postcovid19vaccinedeathssingaporesearlyexperience
AT tanshirui postcovid19vaccinedeathssingaporesearlyexperience
AT chanshijia postcovid19vaccinedeathssingaporesearlyexperience